Bay Colony Advisory Group Inc d b a Bay Colony Advisors Sells 107 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Bay Colony Advisory Group Inc d b a Bay Colony Advisors trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,207 shares of the financial services provider’s stock after selling 107 shares during the quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors’ holdings in iShares Biotechnology ETF were worth $300,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Vontobel Holding Ltd. lifted its holdings in shares of iShares Biotechnology ETF by 9.5% during the first quarter. Vontobel Holding Ltd. now owns 5,060 shares of the financial services provider’s stock worth $659,000 after buying an additional 440 shares in the last quarter. Blair William & Co. IL lifted its holdings in shares of iShares Biotechnology ETF by 9.7% during the first quarter. Blair William & Co. IL now owns 18,717 shares of the financial services provider’s stock worth $2,439,000 after buying an additional 1,659 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 11.7% during the first quarter. NewEdge Advisors LLC now owns 13,777 shares of the financial services provider’s stock worth $1,796,000 after buying an additional 1,445 shares in the last quarter. DCF Advisers LLC acquired a new stake in shares of iShares Biotechnology ETF during the first quarter worth $912,000. Finally, Laurel Wealth Advisors Inc. raised its stake in iShares Biotechnology ETF by 22.6% in the first quarter. Laurel Wealth Advisors Inc. now owns 3,019 shares of the financial services provider’s stock valued at $393,000 after purchasing an additional 557 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.3 %

IBB stock opened at $127.84 on Tuesday. The business has a 50-day simple moving average of $135.82 and a 200 day simple moving average of $129.54. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.